COLDPLASMATECH demonstrated that the CPT® Kaltplasma significantly reduced MRSA bacteria in a porcine model.
Published
Signal category
Research & Knowledge
Quote
“Im tiefdermalen porcinen MRSA-Wundmodell zeigte das großflächige CPT® Kaltplasma gegenüber einer Kontrollgruppe ohne Kaltplasma signifikant niedrigere bakterielle Lasten.”
— COLDPLASMATECH team
Company
COLDPLASMATECH
Ranked #1 and #2 for MedTech | Germany's best companies 2020 to 2022 | FOCUS Money
- Industry
- Medical Device
- Location
- Greifswald, DE
- Company size
- 23 employees
A Star-Trek like medical device that provides the solution to killing multiresistant bacteria and treating chronic wounds. Coldplasmatech GmbH was founded in June 2015 as a spin-off of the Leibniz Institute for Plasma Science and Technology and has been involved in an approval procedure for its innovative medical products (PlasmaPatch and PlasmaCube) since November 2015. Coldplasmatech has attracted attention on various levels. The start-up was listed top successful German start-up in 2014, 2015 and 2016 and has received numerous awards, amongst them the Invention Award, the Leibniz Founder Prize, the IQ Innovation Award and most recently, the Audience Award at INNOVEIT 2017.
Founded 2015